SG Americas Securities LLC Decreases Stock Holdings in Envista Holdings Co. (NYSE:NVST)

SG Americas Securities LLC reduced its stake in shares of Envista Holdings Co. (NYSE:NVST) by 38.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,274 shares of the company’s stock after selling 8,364 shares during the quarter. SG Americas Securities LLC’s holdings in Envista were worth $555,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. NEXT Financial Group Inc purchased a new stake in shares of Envista during the 3rd quarter worth $95,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Envista during the 2nd quarter worth $99,000. Signaturefd LLC raised its stake in Envista by 12,000.0% in the third quarter. Signaturefd LLC now owns 3,025 shares of the company’s stock valued at $126,000 after buying an additional 3,000 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Envista in the second quarter valued at about $152,000. Finally, Private Capital Group LLC raised its stake in Envista by 15.3% in the third quarter. Private Capital Group LLC now owns 4,624 shares of the company’s stock valued at $193,000 after buying an additional 613 shares during the last quarter.

Shares of NYSE NVST opened at $46.31 on Friday. The company has a current ratio of 1.39, a quick ratio of 1.18 and a debt-to-equity ratio of 0.22. Envista Holdings Co. has a 12 month low of $33.75 and a 12 month high of $46.88. The company has a 50 day simple moving average of $42.71 and a two-hundred day simple moving average of $41.96. The stock has a market cap of $7.47 billion, a price-to-earnings ratio of 22.26, a PEG ratio of 0.63 and a beta of 1.75.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, November 3rd. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.40 by $0.05. Envista had a net margin of 13.02% and a return on equity of 9.52%. The business had revenue of $607.30 million during the quarter, compared to analysts’ expectations of $676.69 million. During the same period in the previous year, the business posted $0.48 EPS. Analysts forecast that Envista Holdings Co. will post 1.8 EPS for the current year.

In related news, CEO Amir Aghdaei sold 8,434 shares of the business’s stock in a transaction on Wednesday, December 22nd. The shares were sold at an average price of $44.75, for a total value of $377,421.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Howard H. Yu sold 657 shares of the business’s stock in a transaction on Wednesday, November 17th. The shares were sold at an average price of $42.30, for a total transaction of $27,791.10. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 87,487 shares of company stock valued at $4,020,190. Company insiders own 0.82% of the company’s stock.

A number of equities research analysts have commented on NVST shares. Bank of America upgraded Envista from a “neutral” rating to a “buy” rating and decreased their price target for the company from $49.00 to $48.00 in a research note on Tuesday, October 26th. Zacks Investment Research upgraded Envista from a “sell” rating to a “hold” rating in a research note on Wednesday, January 5th. Finally, Morgan Stanley increased their price target on Envista from $42.00 to $45.00 and gave the company an “equal weight” rating in a research note on Friday, January 7th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $49.40.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.

Further Reading: Do equity income investments outperform growth and income investments?

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.